On the other hand, deficiency of the IL-33/ST2 signalling pathway was shown to protect mice from DSS or TNBS induced colitis and exogenous IL-33 application was recognized to exacerbate bacterial induced colitis (13–15). This evidence concerns the gene IL33 and colitis.